Cologuard vs FIT: the two at-home colon cancer screening tests compared
Last updated September 3, 2026.
If you are due for colon cancer screening and dreading the colonoscopy, two mail-in alternatives exist, and both are legitimate: Cologuard and the FIT test. They work differently, cost differently, and fit different people, but the most important fact is that any screening beats no screening.
How does each test work?
Cologuard is a stool DNA test: you collect a sample at home, mail it to the lab, and it looks for altered DNA and blood associated with colon cancer and advanced precancerous polyps, with screening recommended every three years. Its maker markets Cologuard Plus as the leading noninvasive colon cancer test you collect at home, per its own site, which also notes Medicare Part B is in-network. FIT, the fecal immunochemical test, is simpler: it checks stool for hidden blood and is done every year. Both require a prescription or order, and both end the same way if positive: a follow-up colonoscopy.
What do they cost and what is the catch?
Cologuard is broadly covered by insurance and Medicare Part B, per its own site, which offers an insurance in-network checker. FIT is cheap, often a few dollars to a modest clinic charge, and widely covered. The catches differ: Cologuard catches more, including DNA markers from advanced polyps, but produces more false positives, which means more follow-up colonoscopies for people without cancer. FIT catches less per test but is repeated yearly, and its simplicity makes actually-doing-it-every-year more likely.
Which one should you pick?
Average-risk adults get to choose based on temperament: Cologuard every three years for the more sensitive test, FIT yearly for the simpler one, or the colonoscopy that remains the most complete option and the only one that removes polyps during the exam. High-risk people, with family history, symptoms, or prior polyps, should skip this comparison and get the colonoscopy. Not sure which risk group you are in? Pymander's free AI doctor consult can help you sort it. Emergencies bypass all of it: call 911. Pymander routes emergency red flags to 911, and its escalation logic is documented in its safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
What is the difference between Cologuard and FIT?
Cologuard is a stool DNA test looking for altered DNA and blood, done every three years. FIT checks stool for hidden blood only, done every year. Both are collected at home and both lead to colonoscopy if positive.
Is Cologuard covered by insurance?
Broadly, yes. Cologuard's own site notes Medicare Part B is in-network and offers an insurance checker. Coverage for commercially insured patients is common since colon cancer screening is a preventive benefit.
Which test is more accurate?
Cologuard is more sensitive per test, catching DNA markers FIT misses, but it also produces more false positives. FIT compensates by being repeated annually. Colonoscopy remains the most complete option and can remove polyps during the exam.
Who should not use the at-home tests?
People at high risk: symptoms like bleeding or bowel changes, a personal or strong family history of colon cancer or advanced polyps, or inflammatory bowel disease. They need colonoscopy, not screening by mail.
What happens if my test is positive?
A positive Cologuard or FIT means a follow-up colonoscopy to find out why. Most positives are not cancer, but skipping the follow-up defeats the entire purpose.
What if it is an emergency?
Heavy rectal bleeding or severe abdominal pain is not a screening question; call 911. Pymander is built to recognize emergency red flags in your text and direct you to call rather than continue.
